These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3484937)

  • 41. A survey of isolates of Klebsiella pneumoniae which cross-react with HLA-B27-associated cell-surface structure on the lymphocytes of patients with ankylosing spondylitis.
    Geczy AF; Yap J
    J Rheumatol; 1982; 9(1):97-100. PubMed ID: 7045364
    [No Abstract]   [Full Text] [Related]  

  • 42. Biochemical studies on a factor isolated from Klebsiella K43-BTS1 that cross-reacts with cells from HLA-B27 positive patients with ankylosing spondylitis.
    Upfold LI; Sullivan JS; Geczy AF
    Hum Immunol; 1986 Nov; 17(3):224-38. PubMed ID: 3539895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spondyloarthritis, uveitis, HLA-B27 and Klebsiella.
    Ebringer A; Baines M; Ptaszynska T
    Immunol Rev; 1985 Aug; 86():101-16. PubMed ID: 2412951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA-B27, molecular mimicry, and ankylosing spondylitis: popular misconceptions.
    Geczy AF; Prendergast JK; Sullivan JS; Upfold LI; McGuigan LE; Bashir HV; Prendergast M; Edmonds JP
    Ann Rheum Dis; 1987 Feb; 46(2):171-2. PubMed ID: 3493737
    [No Abstract]   [Full Text] [Related]  

  • 45. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a family and population study.
    van der Linden S; Valkenburg H; Cats A
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):18-9. PubMed ID: 6606472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trial and error in producing ankylosing-spondylitis-selective antisera according to Andrew Geczy.
    Beukelman CJ; Quarles van Ufford HC; van Bree FP; Aerts PC; Nieuwenhoff C; Reerink G; van Leeuwen A; van Dijk H
    Scand J Rheumatol Suppl; 1990; 87():74-9; discussion 79-80. PubMed ID: 2259890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Klebsiella antibodies in ankylosing spondylitis and Proteus antibodies in rheumatoid arthritis.
    Ebringer A; Cox NL; Abuljadayel I; Ghuloom M; Khalafpour S; Ptaszynska T; Shodjai-Moradi F; Wilson C
    Br J Rheumatol; 1988; 27 Suppl 2():72-85. PubMed ID: 3042077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regarding the ankylosing spondylitis/Klebsiella/HLA-B27 problem.
    Terasaki PI; Yu DT
    Arthritis Rheum; 1987 Mar; 30(3):353-4. PubMed ID: 3551967
    [No Abstract]   [Full Text] [Related]  

  • 49. Molecular variants of the HLA-B27 antigen in healthy individuals and patients with spondylarthropathies.
    Turek PJ; Grumet FC; Engleman EG
    Immunol Rev; 1985 Aug; 86():71-91. PubMed ID: 2412952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cross-reactivity of anti-Klebsiella K43 BTS 1 serum and lymphocytes of patients with ankylosing spondylitis: antipodean curiosity?
    Geczy AF; Prendergast JK; McGuigan LE; Upfold LI; Sullivan JS
    Lancet; 1985 May; 1(8438):1169. PubMed ID: 2860379
    [No Abstract]   [Full Text] [Related]  

  • 51. The cross-tolerance hypothesis, HLA-B27 and ankylosing spondylitis.
    Ebringer A
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):53-66. PubMed ID: 6418259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Attempt to show inhibition by oxygen in the modifying factor assay.
    Archer JR; Claxson A; Edwards A; Thompson PW
    Scand J Rheumatol Suppl; 1990; 87():81-4. PubMed ID: 2259891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Preparation and clinical application of HLA-B27 antisera].
    Liu DL
    Zhonghua Yi Xue Za Zhi; 1987 Mar; 67(3):144-6. PubMed ID: 3111660
    [No Abstract]   [Full Text] [Related]  

  • 54. Cross-reacting bacterial determinants in ankylosing spondylitis.
    Sullivan JS; Prendergast JK; Geczy AF; Edmonds JP; McGuigan LE; Edwards CM
    Am J Med; 1988 Dec; 85(6A):54-5. PubMed ID: 2462351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Response to the editorial by Terasaki and Yu on the ankylosing spondylitis/Klebsiella/HLA-B27 problem.
    Geczy AF; Sullivan JS; McGuigan LE
    Arthritis Rheum; 1987 Jun; 30(6):714-5. PubMed ID: 3300661
    [No Abstract]   [Full Text] [Related]  

  • 56. Cross-reactive epitope with Klebsiella pneumoniae nitrogenase in articular tissue of HLA-B27+ patients with ankylosing spondylitis.
    Husby G; Tsuchiya N; Schwimmbeck PL; Keat A; Pahle JA; Oldstone MB; Williams RC
    Arthritis Rheum; 1989 Apr; 32(4):437-45. PubMed ID: 2468338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [An HLA-B27 negative case of ankylosing spondylitis with acute iridocyclitis].
    Yoshikawa M; Nakamura S; Ohno S
    Nippon Ganka Gakkai Zasshi; 1992 Feb; 96(2):271-5. PubMed ID: 1558026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HLA-B27 and HLA-B51 determination in Tunisian healthy subjects and patients with suspected ankylosing spondylitis and Behçet's disease.
    Sakly N; Boumiza R; Zrour-Hassen S; Hamzaoui A; Ben Yahia S; Amara H; Khairallah M; Mahjoub S; Bergaoui N; Ghedira I
    Ann N Y Acad Sci; 2009 Sep; 1173():564-9. PubMed ID: 19758200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiserum to Klebsiella K43 BTS 1 specifically lyses lymphocytes of HLA-B27-positive patients with ankylosing spondylitis from a London population.
    Archer JR; Stubbs MM; Currey HL; Geczy AF
    Lancet; 1985 Feb; 1(8424):344-5. PubMed ID: 2857398
    [No Abstract]   [Full Text] [Related]  

  • 60. Measurement of HLA class I expression in ankylosing spondylitis.
    Creamer P; Edmonds J; Sullivan J; Matthews S
    Ann Rheum Dis; 1992 Oct; 51(10):1138-42. PubMed ID: 1444627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.